← SynDRA
DASABUVIR
SynDRA canonical compound SYN0037844 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | HCV inhibitor |
| Indication | hepatitis C |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
Drug classes
- Breast Cancer Resistance Protein Inhibitors
- Hepatitis C Virus Non-Nucleoside NS5B Palm Polymerase Inhibitor
- RNA Replicase Inhibitors
- UGT1A1 Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- dasabuvir sodium monohydrate
- dasabuvir sodium
- exviera
- ABT-333
- ABT 333
- N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide
- ABT333
- UNII-DE54EQW8T1
- Dasabuvir (ABT-333)
- DE54EQW8T1
- CHEBI:85182
- N-(6-(3-tert-Butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide
- C26H27N3O5S
- Dasabuvir [INN]
- N-{6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]naphthalen-2-yl}methanesulfonamide
- Dasabuvir [USAN:INN]
- Dasabuvir (USA
- dasabuvirum
- RefChem:585200
- J05AP09
- DTXCID901510205
- MFCD27923655
- Dasabuvir (Standard)
- DASABUVIR [MI]
- Dasabuvir(ABT-333)
- Dasabuvir (USAN/INN)
- DASABUVIR [USAN]
- DASABUVIR [VANDF]
- EC 805-439-9
- DASABUVIR [WHO-DD]
- SCHEMBL351053
- orb1304153
- SCHEMBL29362730
- SCHEMBL29838781
- SCHEMBL31554838
- GTPL11270
- EX-A432
- NBRBXGKOEOGLOI-UHFFFAOYSA-N
Look up DASABUVIR in the interactive SynDRA portal →